<DOC>
	<DOCNO>NCT01695109</DOCNO>
	<brief_summary>Clinical experience confirm anorexic effect Glucagon-like-peptide 1 ( GLP-1 ) mimetics comparison DPP-4 inhibitor . A possible mechanism effect might associate change food choice , suggest animal study . It show functional magnetic resonance imaging ( fMRI ) brain valuable tool obesity research use study response several brain region visual presentation prefer comparison non prefer food item non food item The aim study search possible effect liraglutide comparison placebo 1. food choice 2. change brain function evidence fMRI healthy volunteer . Findings study help get deep insight mechanism anorexic effect GLP-1 mimetics , also regulation food choice per se . In future , planned extend result study normal weight volunteer obese diabetic subject .</brief_summary>
	<brief_title>The Influence Liraglutide Reward Properties Food : fMRI Study Healthy Volunteers</brief_title>
	<detailed_description>Design : The study design double blind , placebo control , randomize crossover intervention study two arm ( liraglutide first follow placebo vs. placebo first follow liraglutide ) 16 healthy male volunteer . fMRI result food intake compare group baseline vs. end treatment period placebo vs. liraglutide . Intervention : A standard dose 0.6 mg Liraglutide ( oder placebo ) use , apply subcutaneously morning three subsequent day study personnel . Study session perform fourth day placebo/liraglutide intervention . Study session : On study day participant arrive trial centre 8.00 12h fast . Participants instructed eat light dinner around 8.00 pm previous day spend around 8h rest night study day . Upon arrival , blood pressure heart rate measure iv line start , blood sample take antecubital vein blood glucose , insulin plasma hormone concentration determination . The occurrence nausea , vomit , dizziness adverse event ( AE 's ) review together subject . Instructions fMRI examination review together subject . The subject advise leave ferromagnetic item behind , baseline hunger/satiety visual analogue scale ( VAS ) record . Then , fMRI session food item paradigm ( together repeat recording hunger/satiety VAS ) take place . Afterwards , another blood sample hunger/satiety VAS take subject allow eat ad libitum buffet breakfast . Food intake record detail , include meal choice calorie intake . After final hunger/satiety VAS record another blood sample subject dismiss trial centre . Outcome variable : Main outcome variable fMRI activity brain high calorie/low calorie food item paradigm food intake buffet liraglutide vs. placebo end treatment . Secondary outcome parameter hunger/satiety VAS rating , total active plasma ghrelin , peptide YY ( PYY ) , glucose insulin concentration .</detailed_description>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Male healthy volunteer Age 2040 Nonsmokers Normal body weight ( body mass index 19 25 kg/m2 ) Right hand Signed inform consent Willingness ability comply protocol Any history current drug abuse include alcohol consumption regular basis binge drink Any history current psychiatric disease , include eat disorder , assess structure interview Any history diet Any condition interfere fMRI measurement ferromagnetic implant claustrophobia Any evidence relevant renal , liver , thyroid , cardiovascular , respiratory illness screen examination Any acute illness necessitate medical treatment last 3 week study entry , permanent intake medication Any study participation last 3 month HIV , hepatitis B C positive Any disease consider relevant proper performance study risk participant , discretion investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>GLP1</keyword>
	<keyword>obesity</keyword>
	<keyword>fMRI</keyword>
	<keyword>ghrelin</keyword>
</DOC>